Lab
Laborant LLC
Laborant LLC was paid $214K by Medicaid between Mar 2021 and Mar 2023, across 4 billing codes. Its largest line is 87426, Infectious agent antigen detection, SARS-CoV-2 (COVID-19) — 55% of everything it billed.
33Billing provider infoLABORANT LLC
CORAL SPRINGS, FL 33071
CORAL SPRINGS, FL 33071
33aNPI1659975647assigned 11/30/2020
33bProvider typeClinical Medical Laboratory
28Total paid$214K
24GClaims6,671
24DCodes billed4
24AFirst – last monthMar 2021 – Mar 2023
Compared with peers
Next to other Clinical Medical Laboratory providers in Florida
Rank by total paid#79 of 225
Median peer was paid$74K
This provider vs. median2.9×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2021 | 2,838 | $89K | |
| 2022 | 3,726 | $119K | |
| 2023 | 107 | $6K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 55% | 3,711 | 2,020 | $118K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 43% | 1,372 | 849 | $92K |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | 1.9% | 1,235 | 781 | $4K |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 353 | 219 | $162.11 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialDEMIANCHENKO, MARIIA (OWNER)